IPSC Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 6.80%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $74,670.09

Century Therapeutics Insider Trading History Chart

Century Therapeutics Share Price & Price History

^$0.54

▲ +0.0437 (8.74%)

As of 04/17/2025 05:00 PM ET

Days: 30 | 90 | 365

Century Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/10/2025	Brent Pfeiffenberger	CEO	Sell	2,235	$0.61	$1,363.35	1,190,310
3/10/2025	Douglas Carr	SVP	Sell	1,240	$0.61	$756.40	315,556
3/10/2025	Gregory Russotti	Insider	Sell	2,360	$0.61	$1,439.60	272,573
2/3/2025	Adrienne Farid	Insider	Sell	1,054	$0.78	$822.12	134,076
2/3/2025	Douglas Carr	SVP	Sell	351	$0.78	$273.78	316,796
11/4/2024	Adrienne Farid	Insider	Sell	1,033	$1.23	$1,270.59	135,130
11/4/2024	Douglas Carr	SVP	Sell	283	$1.23	$348.09	317,147
8/5/2024	Adrienne Farid	Insider	Sell	1,073	$1.83	$1,963.59	136,163
8/5/2024	Douglas Carr	SVP	Sell	289	$1.83	$528.87	334,041
7/26/2024	Gregory Russotti	Insider	Sell	586	$2.50	$1,465.00	274,933
7/23/2024	Gregory Russotti	Insider	Sell	200	$2.50	$500.00	277,119
6/20/2024	Gregory Russotti	Insider	Sell	5,000	$2.84	$14,200.00	277,319
6/5/2024	Gregory Russotti	Insider	Sell	5,000	$3.00	$15,000.00	282,319
5/6/2024	Gregory Russotti	Insider	Sell	5,000	$3.12	$15,600.00	292,319
5/3/2024	Adrienne Farid	Insider	Sell	913	$3.11	$2,839.43	137,236
5/3/2024	Douglas Carr	SVP	Sell	257	$3.11	$799.27	317,323
4/22/2024	Gregory Russotti	Insider	Sell	5,000	$3.10	$15,500.00	297,319
3/7/2024	Adrienne Farid	Insider	Sell	22,831	$5.14	$117,351.34	114,149
2/5/2024	Adrienne Farid	Insider	Sell	2,035	$3.84	$7,814.40	115,933
2/5/2024	Douglas Carr	SVP	Sell	643	$3.84	$2,469.12	304,137
3/23/2023	Luis Borges	Insider	Sell	15,597	$3.55	$55,369.35	249,083
3/21/2023	Luis Borges	Insider	Sell	63,616	$3.77	$239,832.32	43,750
8/9/2022	Versant Venture Capital Vi, L.	Major Shareholder	Sell	550,000	$13.03	$7,166,500.00	11,816,814

See Full Table

SEC Filings (Institutional Ownership Changes) for Century Therapeutics (NASDAQ:IPSC)

50.20% of Century Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Century Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/17/2025	VR Adviser LLC	3,957,186	$4M	0.3%	-26.6%	4.654%
2/17/2025	Squarepoint Ops LLC	164,871	$0.17M	0.0%	+56.0%	0.194%
2/17/2025	Two Sigma Investments LP	66,797	$67K	0.0%	N/A	0.079%
2/17/2025	Two Sigma Advisers LP	51,000	$52K	0.0%	N/A	0.060%
2/17/2025	Nuveen Asset Management LLC	157,311	$0.16M	0.0%	+48.9%	0.185%
2/17/2025	Millennium Management LLC	1,607,174	$1.62M	0.0%	+1,041.8%	1.890%
2/17/2025	Deutsche Bank AG	193,368	$0.20M	0.0%	+890.7%	0.227%
2/17/2025	Casdin Capital LLC	5,190,506	$5.24M	0.3%	+61.6%	6.104%
2/17/2025	Bank of America Corp DE	66,043	$67K	0.0%	+109.1%	0.078%
2/14/2025	Jane Street Group LLC	48,036	$49K	0.0%	+166.2%	0.056%
2/14/2025	Northern Trust Corp	336,989	$0.34M	0.0%	-4.4%	0.396%
2/13/2025	Marshall Wace LLP	35,511	$36K	0.0%	N/A	0.042%
2/13/2025	XTX Topco Ltd	85,993	$87K	0.0%	N/A	0.101%
2/13/2025	Renaissance Technologies LLC	1,202,885	$1.22M	0.0%	+146.4%	1.415%
2/12/2025	Geode Capital Management LLC	991,595	$1M	0.0%	+2.4%	1.166%
2/12/2025	JPMorgan Chase & Co.	163,189	$0.17M	0.0%	+127.5%	0.192%
2/11/2025	Sei Investments Co.	52,748	$53K	0.0%	N/A	0.062%
12/26/2024	JPMorgan Chase & Co.	71,721	$0.12M	0.0%	+257.6%	0.084%
11/19/2024	Barclays PLC	61,945	$0.11M	0.0%	+283.6%	0.073%
11/16/2024	Geode Capital Management LLC	968,182	$1.66M	0.0%	+3.5%	1.139%
11/15/2024	Barclays PLC	61,945	$0.11M	0.0%	+283.6%	0.073%
11/15/2024	Jane Street Group LLC	18,044	$31K	0.0%	-77.6%	0.021%
11/15/2024	Wellington Management Group LLP	166,123	$0.28M	0.0%	N/A	0.195%
11/15/2024	State Street Corp	836,914	$1.43M	0.0%	+7.4%	0.984%
11/13/2024	FMR LLC	2,521,511	$4.31M	0.0%	-14.5%	2.965%
11/12/2024	Charles Schwab Investment Management Inc.	355,331	$0.61M	0.0%	-10.8%	0.418%
11/6/2024	Cornercap Investment Counsel Inc.	25,978	$44K	0.0%	-49.1%	0.031%
10/3/2024	SG Americas Securities LLC	16,081	$27K	0.0%	N/A	0.019%
8/9/2024	Renaissance Technologies LLC	165,500	$0.42M	0.0%	+6.1%	0.196%
8/9/2024	Dimensional Fund Advisors LP	75,315	$0.19M	0.0%	+141.7%	0.089%
8/8/2024	Federated Hermes Inc.	276,163	$0.70M	0.0%	-55.1%	0.327%
8/1/2024	Rhumbline Advisers	52,466	$0.13M	0.0%	+56.0%	0.062%
7/26/2024	Bank of New York Mellon Corp	149,000	$0.38M	0.0%	+110.1%	0.176%
5/16/2024	Jacobs Levy Equity Management Inc.	293,941	$1.23M	0.0%	+191.0%	0.453%
5/10/2024	Vanguard Group Inc.	1,138,653	$4.76M	0.0%	+1.2%	1.757%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	11,130	$47K	0.0%	N/A	0.017%
2/28/2024	Abel Hall LLC	10,071	$33K	0.0%	N/A	0.017%
2/14/2024	Avidity Partners Management LP	1,355,000	$4.50M	0.2%	+23.4%	2.265%
2/6/2024	New York Life Investment Management LLC	99,912	$0.33M	0.0%	-2.6%	0.167%
1/31/2024	Federated Hermes Inc.	618,482	$2.05M	0.0%	+0.4%	1.034%
11/14/2023	Avidity Partners Management LP	1,098,500	$2.20M	0.1%	-1.1%	1.836%
11/13/2023	FMR LLC	4,524,629	$9.05M	0.0%	-12.5%	7.562%
11/8/2023	New York Life Investment Management LLC	102,606	$0.21M	0.0%	-13.6%	0.172%
8/7/2023	Acadian Asset Management LLC	50,078	$0.16M	0.0%	-18.6%	0.084%
8/7/2023	New York Life Investment Management LLC	118,771	$0.38M	0.0%	-11.3%	0.199%
5/12/2023	Martingale Asset Management L P	49,151	$0.17M	0.0%	N/A	0.082%
5/11/2023	Cornercap Investment Counsel Inc.	52,175	$0.18M	0.0%	N/A	0.088%
5/9/2023	Gladius Capital Management LP	7,730	$27K	0.0%	N/A	0.013%
5/8/2023	New York Life Investment Management LLC	133,829	$0.46M	0.0%	N/A	0.225%
2/9/2023	Mirae Asset Global Investments Co. Ltd.	12,622	$65K	0.0%	N/A	0.021%
2/2/2023	SG Americas Securities LLC	10,368	$53K	0.0%	N/A	0.018%
1/23/2023	Allspring Global Investments Holdings LLC	7,992	$41K	0.0%	N/A	0.014%
11/15/2022	Logos Global Management LP	460,075	$4.55M	0.6%	-3.5%	0.780%
11/14/2022	Point72 Asset Management L.P.	165,200	$1.63M	0.0%	-65.7%	0.281%
11/14/2022	HarbourVest Partners LLC	29,018	$0.29M	0.1%	+98.3%	0.049%
11/7/2022	Nisa Investment Advisors LLC	12,000	$0.13M	0.0%	N/A	0.020%
11/3/2022	Parametrica Management Ltd	27,840	$0.28M	0.6%	-3.5%	0.047%
8/16/2022	DAFNA Capital Management LLC	475,367	$3.99M	1.1%	+85.0%	0.807%
8/16/2022	Delphia USA Inc.	10,548	$89K	0.1%	N/A	0.018%
8/15/2022	Point72 Asset Management L.P.	481,000	$4.04M	0.0%	+2.9%	0.817%
8/12/2022	FMR LLC	7,576,385	$63.64M	0.0%	-7.9%	12.874%
8/8/2022	Walleye Capital LLC	78,698	$0.66M	0.0%	+54.6%	0.134%
7/29/2022	Russell Investments Group Ltd.	3,308	$27K	0.0%	N/A	0.006%
7/22/2022	Parametrica Management Ltd	28,855	$0.24M	0.3%	N/A	0.049%
5/27/2022	Walleye Capital LLC	50,908	$0.64M	0.0%	-18.5%	0.087%
5/16/2022	Deep Track Capital LP	926,469	$11.66M	0.7%	+270.6%	1.575%
5/5/2022	New York State Common Retirement Fund	13,651	$0.17M	0.0%	+76.9%	0.023%
3/3/2022	Walleye Capital LLC	62,471	$0.99M	0.0%	N/A	0.114%
2/19/2022	Woodline Partners LP	208,082	$3.30M	0.0%	-16.8%	0.381%
2/15/2022	Marshall Wace LLP	701,338	$11.12M	0.0%	+528.7%	1.284%
2/14/2022	Point72 Asset Management L.P.	410,800	$6.52M	0.0%	N/A	0.752%
2/14/2022	DAFNA Capital Management LLC	100,135	$1.59M	0.4%	+25.2%	0.183%
2/14/2022	Deep Track Capital LP	250,000	$3.97M	0.3%	N/A	0.458%
2/14/2022	HarbourVest Partners LLC	14,631	$0.23M	0.0%	N/A	0.027%
2/8/2022	ProShare Advisors LLC	10,273	$0.16M	0.0%	N/A	0.019%
2/7/2022	Royce & Associates LP	12,900	$0.21M	0.0%	N/A	0.024%
2/2/2022	New York State Common Retirement Fund	7,718	$0.12M	0.0%	+267.5%	0.014%
1/28/2022	Allspring Global Investments Holdings LLC	15,545	$0.25M	0.0%	N/A	0.028%
11/16/2021	Schonfeld Strategic Advisors LLC	13,600	$0.34M	0.0%	-24.9%	0.025%
11/16/2021	Metropolitan Life Insurance Co NY	3,737	$94K	0.0%	N/A	0.007%
11/15/2021	Marshall Wace LLP	111,552	$2.81M	0.0%	+111.5%	0.205%
11/12/2021	Ghisallo Capital Management LLC	15,000	$0.38M	0.0%	-50.0%	0.028%
11/12/2021	Parametrica Management Ltd	28,755	$0.72M	0.5%	N/A	0.053%
11/12/2021	Geode Capital Management LLC	204,691	$5.15M	0.0%	+429.4%	0.376%
11/10/2021	Citigroup Inc.	1,335	$34K	0.0%	N/A	0.002%
11/9/2021	BlackRock Inc.	648,656	$16.32M	0.0%	N/A	1.192%
11/4/2021	Deutsche Bank AG	6,795	$0.17M	0.0%	N/A	0.012%
11/2/2021	New York State Common Retirement Fund	2,100	$53K	0.0%	N/A	0.004%
11/1/2021	SG Americas Securities LLC	5,314	$0.13M	0.0%	N/A	0.010%
10/22/2021	Strs Ohio	2,700	$67K	0.0%	N/A	0.005%
8/25/2021	Marshall Wace LLP	52,749	$1.55M	0.0%	N/A	0.097%
8/25/2021	Marshall Wace North America L.P.	247,251	$7.25M	0.0%	N/A	0.454%
8/17/2021	Woodline Partners LP	281,726	$8.27M	0.2%	N/A	0.514%
8/17/2021	Sphera Funds Management LTD.	80,000	$2.35M	0.2%	N/A	0.146%
8/17/2021	Logos Global Management LP	989,095	$29.02M	2.5%	N/A	1.804%
8/17/2021	Millennium Management LLC	181,164	$5.32M	0.0%	N/A	0.330%
8/17/2021	Octagon Capital Advisors LP	403,523	$11.84M	2.5%	N/A	0.736%
8/17/2021	Caas Capital Management LP	30,000	$0.88M	0.0%	N/A	0.055%
8/16/2021	LMR Partners LLP	49,323	$1.45M	0.0%	N/A	0.090%
8/16/2021	Hhlr Advisors LTD.	614,095	$18.02M	0.2%	N/A	1.120%

Data available starting January 2016

See Full Table

Century Therapeutics, Inc., a biotechnology company, engages in the development of genetically engineered allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. Its lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy, under Phase 1 trials targeting CD19 for relapsed, refractory B-cell lymphoma. The company is also involved in the development of CNTY-102, a bi-specific CD19 + CD22 CAR-iT product candidate for relapsed, refractory B-cell lymphoma and other B-cell malignancies; and CNTY-107, a Nectin-4 CAR-iT targeted product candidate for Nectin-4 positive solid tumors. In addition, it has a strategic collaboration with Bristol-Myers Squibb Company to develop and commercialize up to four iNK or iT programs, including CNTY-104, a multi-specific collaboration program targeting acute myeloid leukemia; and CNTY-106, a multi-specific collaboration program for multiple myeloma. The company was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania.

Today's Range

Now: $0.54

$0.50

$0.56

50 Day Range

MA: $0.58

$0.39

$0.77

52 Week Range

Now: $0.54

$0.34

$3.70

Volume

657,515 shs

Average Volume

409,673 shs

Market Capitalization

$46.78 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.83

Who are the company insiders with the largest holdings of Century Therapeutics?: Century Therapeutics' top insider investors include:
Brent Pfeiffenberger (CEO)
Douglas Carr (SVP)
Gregory Russotti (Insider)
Adrienne Farid (Insider)
Learn More about top insider investors at Century Therapeutics.